Actively Recruiting
MEthods for LOcalization of Different Types of Breast Lesions
Led by European Breast Cancer Research Association of Surgical Trialists · Updated on 2025-03-03
7416
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
Sponsors
E
European Breast Cancer Research Association of Surgical Trialists
Lead Sponsor
I
iBRA-NET
Collaborating Sponsor
AI-Summary
What this Trial Is About
In the last decades, the proportion of breast cancer (BC) patients receiving breast-conserving surgery has increased steadily, reaching 70-80% in developed countries. Since positive resection margins are strongly associated with local recurrence risk, the goal of breast surgery is the complete tumor removal and most national and international guidelines recommend re-operation, either in form of re-excision or mastectomy, until clear margins have been reached. Re-operation rates vary widely, with population-based studies reporting a range of 15-35%, and the necessity for a second surgery can lead to increased patient anxiety, a delay in start of adjuvant treatment, worse cosmetic outcome and increased complication rates and costs. Therefore, re-operation rate has been included as a quality indicator in several countries. Several imaging-guided techniques have been developed to guide removal of non-palpable breast lesions, the oldest one being preoperative wire placement under ultrasound or mammographic guidance, usually followed by radiography or ultrasound of removed tissue. Newer techniques, such as intraoperative ultrasound (IOUS), radioguided occult lesion localization (ROLL), radioactive seed localization (RSL), radar reflector-localization (RRL), magnetic seed localization (MSL), and radiofrequency identification (RFID) tags have been introduced as an alternative to wire-guided localization (WGL). To date, comparative data on the rates of successful lesion removal, negative margins, re-operation rate and patient's comfort depending on the localization technique used are limited. Further, since some of these studies were funded by the manufacturer of the marker examined, a potential bias cannot be excluded. In the vast majority of the available studies, the patient's perspective with regard to discomfort and pain level has not been evaluated. The aim of the proposed study is to comparatively evaluate different imaging-guided localization methods used for surgical removal of malignant breast lesions with regard to oncological safety and patient-reported outcomes.
CONDITIONS
Official Title
MEthods for LOcalization of Different Types of Breast Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent form
- Malignant breast lesion requiring breast-conserving surgery and imaging-guided localization (either DCIS or invasive breast cancer; multiple or bilateral lesions and the use of neoadjuvant chemotherapy are allowed)
- Planned surgical removal of the lesion using one or more of the following imaging-guided localization techniques: wire-guided localization, intraoperative ultrasound, magnetic localization, radioactive seed localization, Radioguided Occult Lesion Localization (ROLL), radar localization, radiofrequency identification (RFID) tag localization, ink/carbon localization
- Female or male patients 18 years old or older
You will not qualify if you...
- Patients not suitable for surgical treatment
- Patients requiring mastectomy as first surgery
- Surgical removal without imaging-guided localization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Schleswig-Holstein Campus Lübeck
Lübeck, Germany
Actively Recruiting
Research Team
M
Maggie Banys-Paluchowski, Priv.-Doz. Dr. med.
CONTACT
T
Thorsten Kühn, Prof. Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
8
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here